Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$231,004,675
+$4,703,553 QoQ
Shares Held
637,923
-0.8% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#77
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Boston Partners holds $3,635,506,449 across 12 Drug Manufacturers - General names. AMGN ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,784,316 | $1,203,925,277 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,017,958 | $760,308,811 | |
| 3 | AZN |
Astrazeneca PLC
|
3,177,627 | $602,541,630 | |
| 4 | JNJ |
Johnson & Johnson
|
1,113,805 | $282,873,054 | |
| 5 | BIIB |
Biogen Inc.
|
1,263,429 | $272,976,467 | |
| 6 | AMGN |
Amgen Inc
This page
|
637,923 | $231,004,675 | |
| 7 | SNY |
Sanofi
|
3,844,844 | $164,021,044 | |
| 8 | MRK |
Merck & Co., Inc.
|
629,240 | $80,857,340 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $231,004,675 | 637,923 | Shares | Other | 2026-08-04 | |
| 2026-03-31 | $226,301,122 | 643,175 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $237,231,995 | 724,793 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $204,237,734 | 723,734 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $208,956,853 | 748,386 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $250,300,826 | 803,405 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $589,466,810 | 2,261,613 | Shares | Other | 2025-02-11 | |
| 2024-09-30 | $738,563,315 | 2,292,180 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $716,888,403 | 2,294,410 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $636,118,800 | 2,237,334 | Shares | Other | 2024-05-28 | |
| 2023-12-31 | $505,797,680 | 1,756,120 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $532,332,662 | 1,980,699 | Shares | Other | 2023-11-08 | |
| 2023-06-30 | $445,620,557 | 2,007,119 | Shares | Other | 2023-08-10 | |
| 2023-03-31 | $442,152,771 | 1,828,967 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $252,310,105 | 960,669 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $259,512,034 | 1,151,340 | Shares | Other | 2022-11-09 | |
| 2022-06-30 | $287,400,312 | 1,181,259 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $279,157,248 | 1,154,401 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $255,348,822 | 1,135,035 | Shares | Defined | 2022-02-04 | |
| 2021-09-30 | $153,681,728 | 722,698 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $168,903,637 | 692,938 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $290,839,233 | 1,168,921 | Shares | Other | 2021-05-10 | |
| 2020-12-31 | $223,615,362 | 972,579 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $5,209,771 | 20,498 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,120,756 | 21,711 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,852,613 | 14,071 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||